Tenet Healthcare Corporation is one of the largest investor-owned healthcare services companies in the United States. Headquartered in Dallas, Texas, the company operates 65 acute care hospitals and over 450 healthcare facilities, including ambulatory surgery centers and other outpatient facilities. ​ As of late 2025, Tenet reported trailing twelve-month revenue of approximately $20.8 billion, a…

This interview analysis is sponsored by CCC and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. AI is advancing across enterprise workflows faster than governance frameworks and licensing structures can keep pace. Gaps in…

Bankers are flooded with market signals, filings, and global events, yet lack tools to filter out what actually matters for each client, creating information overload that slows decision-making and weakens the impact of advisory. Research from the Boston College Center for Retirement Research shows that as financial complexity rises, investors reduce processing effort, and individuals…

Allianz Group is one of the world's leading insurers and asset managers serving approximately 125 million private and corporate customers across nearly 70 countries. In 2024, the company reported total business volume of $208 billion USD and operating profit of $18.5 billion, per an Allianz media release. Although Allianz does not publicly disclose precise investment…

Maintaining legacy IT platforms has become a massive financial and operational drag. Research from Pegasystems Inc., in partnership with research firm Savanta, found that the average global enterprise wastes more than USD $370 million each year on technical debt. The primary reason for this technical debt cited in the study is that legacy transformation projects…

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Life sciences organizations stand at a paradoxical moment in AI adoption. The technology’s potential is visible in discovery,…

Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems that deliver measurable operational improvements. At the same time, they must keep these systems safe, explainable, and aligned with human judgment. Errors in these contexts carry real human and economic consequences. In manufacturing, these…

Bristol Myers Squibb is a global biopharmaceutical leader dedicated to delivering innovative medicines across oncology, hematology, immunology, cardiovascular disease, and neuroscience. The company serves patients worldwide through a comprehensive portfolio of breakthrough therapies developed across multiple therapeutic areas. In 2024, Bristol Myers Squibb reported annual revenue of $48.3 billion according to company earnings reports. At…

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Government and industry leaders increasingly agree that governance is now foundational to AI — not optional — because…

This interview analysis is sponsored by AnswerRocket and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Enterprise organizations face decision-making pressures that are strikingly consistent across industries. As product portfolios expand, markets fragment, and…

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high as $2 billion per drug and are accompanied by protracted timelines of 10-15 years. Pharmaceutical companies are turning to AI to shorten discovery timelines while dramatically upholding rigorous standards.​ AI-driven approaches have demonstrated meaningful…

SMBs are overwhelmed by multi-step operational work that drains time and headcount. Global trade processes remain slow, fragmented, and opaque. For all the focus on large enterprises in AI adoption, World Trade Organization working group documentation notes that SMBs make up nearly 90–95% of all global businesses and account for 60% of worldwide employment. Other…